Estrogen Enhances The Chances Of Surviving Colon Cancer
Posted by Admin | Posted in Cancer, Health News | Posted on 25-01-2010
0
Both men and women suffer from this deadly and widespread disease. It has concluded that women suffering from colon cancer have a longer life-span than men who have the same disease at the advanced stages. But as women start growing older the chances become bleak as there is decline in the estrogen levels.
Earlier research states that women have lesser chances than men to develop this painful and deadly disease as the diagnosis of the disease generally happens at advanced stages.
New research on colon cancer
Researcher Heinz-Josef Lenz, MD, of the University of Southern California has confirmed that estrogen enhances the chances and results of premenopausal women and catalyzes the cure of cancer in a refined way. Young women have better and magnified chances of getting cured from colorectal cancer as compared to men. This conclusion has been drawn by Lenz who works at the colorectal cancer center at USC’s Norris Comprehensive Cancer Center/Keck School of Medicine.
Lenz and his analyisis
In USA approximately 150,000 fresh cases of colon cancer have been acknowledged and in 90% of the cases it occurs to people above the age of 50 years as per ACS – American Cancer Society. The disorder is very nasty when younger adults suffer from this cancer.
Lenz and his colleagues have examined data from a gigantic cancer research institute that has a national presence and they conclude that around 53,000 patients were treated between the year 1988 and 2004 that were ailing from colorectal cancer. The chance of survival is very diverse between men and women. Women that are less than forty years old have better longevity than men of the similar age.
Ratio of Survival
The chances of survival are equal if men and women are between forty five years and fifty years. If women are above fifty years and if the cancer is well spread in the body then men have better chances of living than women. The research was conducted in all the various ethnic tribes and gender discrepancy was magnified amongst young patients that were treated after the year 1999. This assessment has been displayed in Clinical Cancer Research journal. Younger women have refined chances of benefiting from the drug than men as there are assorted options of cure.
The role of Estrogen
No one knows how estrogen shields against colorectal cancer as there are many theories relating to it. It is a fact that as women grow old the levels of estrogen becomes lower and this acts as impediment and facilitates the tumor to grow and create damage to them.
According to American Cancer Society Director of Prostate and Colorectal Cancers Durado Brooks, MD the assessment is very interesting but the logic needs to be scrutinized as it would be beneficial in treating colorectal cancer. He has announced that it is too premature to state whether estrogen along with chemotherapy sessions will cause a path breaking change in the treatment or not. Current studies focus on hormone replacement cure that aids in eliminating the chances of developing the deadly disease.